CENDARA Bioscience is a specialist pharma advisory firm with a singular mission: eliminate the wasted months that cost pharmaceutical companies tens of millions of dollars between the decision to outsource development and the moment a CDMO programme runs at full speed. We deploy embedded expert resource, compress development timelines by 30–60%, and generate fees only when we deliver measurable value.
Sponsors pay nothing upfront. Placement fees are charged to the CDMO; performance bonuses are triggered only by verified time savings. We absorb the risk and earn by delivering results.
We do not deliver a report and step away. Our specialists sit within the programme team, working alongside sponsor scientists and CDMO project managers every week throughout the engagement.
We integrate digital twin technology, real-time data environments, and AI-augmented process modelling into every programme. This helps sponsors assess and select CDMOs with genuine digital maturity and competitive advantage.